A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention)

Mikkel Bandak; Niels Jørgensen; Anders Juul; Jakob Lauritsen; Michael Kreiberg; Peter Sandor Oturai; Jorn Wulff Helge; Gedske Daugaard

doi:10.1186/s12885-017-3456-5

A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention)

Mikkel Bandak, Niels Jørgensen, Anders Juul, Jakob Lauritsen, Michael Kreiberg, Peter Sandor Oturai, Jorn Wulff Helge, Gedske Daugaard

4 Citations (Scopus)

72 Downloads (Pure)

Original language	English
Article number	461
Journal	B M C Cancer
Volume	17
Number of pages	8
ISSN	1471-2407
DOIs	https://doi.org/10.1186/s12885-017-3456-5
Publication status	Published - 3 Jul 2017

Keywords

Testicular cancer
Mild Leydig cell insufficiency
Testosterone substitution

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/s12885-017-3456-5Licence: CC BY

A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention)Final published version, 718 KBLicence: CC BY

Cite this

@article{184a258204d947faa5a2e2cf430fd17e,

title = "A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention)",

keywords = "Testicular cancer, Mild Leydig cell insufficiency, Testosterone substitution",

author = "Mikkel Bandak and Niels J{\o}rgensen and Anders Juul and Jakob Lauritsen and Michael Kreiberg and Oturai, {Peter Sandor} and Helge, {Jorn Wulff} and Gedske Daugaard",

year = "2017",

month = jul,

day = "3",

doi = "10.1186/s12885-017-3456-5",

language = "English",

volume = "17",

journal = "B M C Cancer",

issn = "1471-2407",

publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention)

AU - Bandak, Mikkel

AU - Jørgensen, Niels

AU - Juul, Anders

AU - Lauritsen, Jakob

AU - Kreiberg, Michael

AU - Oturai, Peter Sandor

AU - Helge, Jorn Wulff

AU - Daugaard, Gedske

PY - 2017/7/3

Y1 - 2017/7/3

KW - Testicular cancer

KW - Mild Leydig cell insufficiency

KW - Testosterone substitution

U2 - 10.1186/s12885-017-3456-5

DO - 10.1186/s12885-017-3456-5

M3 - Journal article

C2 - 28673265

SN - 1471-2407

VL - 17

JO - B M C Cancer

JF - B M C Cancer

M1 - 461

ER -

A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention)

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this